CargoAdmin, Bureaucrats, Moderators (CommentStreams), fileuploaders, Interface administrators, newuser, Push subscription managers, Suppressors, Administrators
5,230
edits
Allergenic Products Advisory Committee: Difference between revisions
Allergenic Products Advisory Committee (view source)
Revision as of 22:42, 21 February 2025
, 21 Februaryno edit summary
(Created page with "{{Organization |OrganizationName=Allergenic Products Advisory Committee |OrganizationType=Boards, Commissions, and Committees |Mission=The Allergenic Products Advisory Committee advised the FDA on the safety, effectiveness, and labeling of allergenic biological products for human use until its termination in 2024. It evaluated data on products for allergy diagnosis, prevention, and treatment, providing recommendations to the FDA Commissioner to ensure public health st...") |
No edit summary |
||
| Line 16: | Line 16: | ||
}} | }} | ||
'''Allergenic Products Advisory Committee (APAC)''' was an advisory body within the Food and Drug Administration (FDA), established on July 9, 1984, to assess allergenic biological products like extracts used for diagnosing and treating allergies, until its termination on July 9, 2024. Comprising nine core voting members with expertise in allergy, immunology, and related fields, APAC reviewed data on safety, efficacy, and labeling, holding infrequent meetings—such as those in 2016, 2019, and 2021—before its duties were absorbed by the Vaccines and Related Biological Products Advisory Committee (VRBPAC) due to low utilization. | '''Allergenic Products Advisory Committee (APAC)''' was an advisory body within the Food and Drug Administration (FDA), established on July 9, 1984, to assess allergenic biological products like extracts used for diagnosing and treating allergies, until its termination on July 9, 2024. Comprising nine core voting members with expertise in allergy, immunology, and related fields, APAC reviewed data on safety, efficacy, and labeling, holding infrequent meetings—such as those in 2016, 2019, and 2021—before its duties were absorbed by the [[Vaccines and Related Biological Products Advisory Committee]] (VRBPAC) due to low utilization. | ||
{{Official URL (simple)|url=https://www.fda.gov/advisory-committees/allergenic-products-advisory-committee}} | {{Official URL (simple)|url=https://www.fda.gov/advisory-committees/allergenic-products-advisory-committee}} | ||